Table 1 Patient’s characteristics
Age, years | 62 ± 17 |
Sex | Male (79%) |
NYHA functional class III-IV | 17 (21%) |
(I 31; II 33; III 15; IV 2) | |
Etiology | |
IHD | 22 (27%) |
Non-IHD | 59 (73%) |
Valvular disease | 4 (5%) |
DCM | 37 (46%) |
HCM | 5 (6%) |
HHD | 7 (9%) |
Others | 6 (7%) |
Electrocardiogram | |
Sinus rhythm | 54 (67%) |
Atrial fibrillation | 19 (23%) |
Pacing rhythm | 8 (10%) |
Medications | |
Beta-blocker | 62 (78%) |
ACE-I/ARB | 65 (80%) |
Calcium channel blocker | 16 (20%) |
Diuretic | 61 (75%) |
Aldosterone antagonist | 47 (58%) |
Laboratory test | |
BNP (pg/mL) | 765 ± 870 |
Uric acid (mg/dL) | 7.4 ± 2.6 |
Hemoglobin (g/dL) | 14.0 ± 2.1 |
Total bilirubin (mg/dL) | 1.1 ± 0.8 |
C-reactive protein (mg/dL) | 1.5 ± 2.9 |
eGFR (mL/min/1.73 m2) | 51 ± 20 |
Echocardiographic examination | |
LAD (cm) | 4.1 ± 0.8 |
IVSTd (cm) | 1.0 ± 0.3 |
LVPWTd (cm) | 1.1 ± 0.3 |
LVDd (cm) | 6.1 ± 1.0 |
LVDs (cm) | 5.4 ± 1.1 |
LVEF (%) | 30 ± 8 |
RVFAC (%) | 35 ± 14 |
TR-PG (mmHg) | 25 ± 12 |